Compile Data Set for Download or QSAR
Report error Found 127 Enz. Inhib. hit(s) with all data for entry = 2055
TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351755(US9796716, Compound 1)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351756(US9796716, Compound 2)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351757(US9796716, Compound 3)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351758(US9796716, Compound 4)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351759(US9796716, Compound 5)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351760(US9796716, Compound 6)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351761(US9796716, Compound 7)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351762(US9796716, Compound 8)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351763(US9796716, Compound 9)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351764(US9796716, Compound 10)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351765(US9796716, Compound 11)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351766(US9796716, Compound 15 | US9796716, Compound 12)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351767(US9796716, Compound 13)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351768(US9796716, Compound 14)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351766(US9796716, Compound 15 | US9796716, Compound 12)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351770(US9796716, Compound 16)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351771(US9796716, Compound 17)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351772(US9796716, Compound 18)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351773(US9796716, Compound 19)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351774(US9796716, Compound 20)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351775(US9796716, Compound 21)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351776(US9796716, Compound 22)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351777(US9796716, Compound 23)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351778(US9796716, Compound 24)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351780(US9796716, Compound 25)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351782(US9796716, Compound 26)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351783(US9796716, Compound 27)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351784(US9796716, Compound 28)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351785(US9796716, Compound 29)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351786(US9796716, Compound 30)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351787(US9796716, Compound 31)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351788(US9796716, Compound 32)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351789(US9796716, Compound 33)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351790(US9796716, Compound 34)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351791(US9796716, Compound 35)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351792(US9796716, Compound 36)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351793(US9796716, Compound 37)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351794(US9796716, Compound 38)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351795(US9796716, Compound 39)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351796(US9796716, Compound 40)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351797(US9796716, Compound 41)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351798(US9796716, Compound 42)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351799(US9796716, Compound 43)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351800(US9796716, Compound 44)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351802(US9796716, Compound 46)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351803(US9796716, Compound 47)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351804(US9796716, Compound 48)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351805(US9796716, Compound 49)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351806(US9796716, Compound 50)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Pharmascience

US Patent
LigandPNGBDBM351807(US9796716, Compound 51)
Affinity DataKi: <100nMAssay Description:Fluorescence polarization-based kinase assays were performed in 384 well-plate format using histidine tagged recombinant human full-length Bruton Aga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 127 total ) | Next | Last >>
Jump to: